Autopsy report · NCT05526079

Watchful Waiting for Complete Responders to Therapy in Rectal Cancer

“Lack of financial support”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 2 months after it had already started.
• Ran for about 7 years 9 months before it stopped.
• 15 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Henry Ford Health System

Sponsor type

University, hospital or other

Conditions

Rectal Cancer

Interventions

Watchfuf waiting

Participants

15

Sites

1

Countries

United States

Trials that died the same way

• Impact of Surgical Theater's Patient Engagement
  “Lack of support/funding” (86% match in meaning)
• ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases
  “no financial support” (86% match in meaning)
• Effects of Empowerment-based Program on Post-discharge Glycemic Control, and Foot Ulcer
  “Lack of financial resources” (82% match in meaning)
• Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer
  “No financial support aproved” (80% match in meaning)
• Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
  “Lack of financial support and low inclusion rate” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.